Skip to search.
 TSX Down 0.02% TSX Ventures Up 0.42%

OncoGenex Pharmaceuticals, Inc. (OGXI)

-NasdaqCM
1.85 Down 0.04(2.12%) May 22, 4:00PM EDT
Add to Portfolio
Prev Close:1.89
Open:1.90
Bid:1.70 x 100
Ask:2.49 x 100
1y Target Est:5.50
Beta:0.74
Earnings Date:Aug 5 - Aug 10 (Est.)
Day's Range:1.83 - 1.91
52wk Range:1.74 - 4.33
Volume:98,773
Avg Vol (3m):200,545
Market Cap:58.02M
P/E (ttm):N/A
EPS (ttm):-1.45
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
OGXIDown 2.12%58.02M
BMYDown 0.86%113.85B
CELGDown 0.09%92.08B
PFEDown 0.23%211.08B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):1.58
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-15) :-0.97
Quarterly EPS Est (Jun-15) :0.34
Mean Recommendation*:1.5
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

OncoGenex Pharmaceuticals, Inc., a biopharmaceutical company, develops and commercializes therapies that address treatment resistance in cancer patients. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback